Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the therapeutic benefits of pentoxifylline (PTX) in treatment of
adult patients with MDD as it has anti-inflammatory and phosphodiastrase inhibition
activities.